Despite the volatility brought about by different economic cycles, the profit margins of the medical industry remain stable, given the consistent demand for its products and services. The sector looks well-positioned for solid growth due to growing medical needs and the adoption of the latest technologies.
Amid this backdrop, it could be wise to buy fundamentally strong medical stocks GSK plc (GSK), National HealthCare Corporation (NHC), and MiMedx Group, Inc. (MDXG). These stocks are all rated A (Strong Buy) in our proprietary POWR Ratings system.
